Page last updated: 2024-08-16

risperidone and lactic acid

risperidone has been researched along with lactic acid in 29 studies

Research

Studies (29)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	6 (20.69)	29.6817
2010's	22 (75.86)	24.3611
2020's	1 (3.45)	2.80

Authors

Authors	Studies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Al-Rawi, PG; Czosnyka, M; Gimson, A; Hutchinson, PJ; Menon, DK; O'Connell, MT	1
Cui, Y; He, HB; Lu, YX; Tang, X	1
Lu, Y; Tang, X; Yu, Y	1
Budhian, A; Ehrlichman, RS; Liang, Y; Majewski-Tiedeken, C; Metzger, KL; Rabin, C; Siegel, SJ; Winey, KI	1
Mishra, A; Muthu, MS; Rawat, MK; Singh, S	1
Jiang, C; Li, Y; Meng, Q; Shi, Y; Su, Z; Sun, F; Teng, L	1
Li, X; Li, YX; Meng, QF; Shi, YN; Su, ZX; Teng, LR; Teng, LS; Wang, LX	1
Amann, LC; Gandal, MJ; Liang, Y; Lin, R; Siegel, SJ	1
Hu, Z; Jin, T; Liu, Y; Su, J; Wu, F; Yuan, W	1
Burgess, DJ; Rawat, A; Shah, VP; Stippler, E	1
Cai, C; Gou, J; Guo, P; He, H; Lin, X; Qi, N; Tang, X; Yang, S; Zhang, Y; Zhao, M	1
Bhardwaj, U; Burgess, DJ; Rawat, A	1
Blasi, P; DeLuca, PP; Selmin, F	1
D'Souza, S; DeLuca, P; Faraj, J	1
Lu, Y; Park, K; Sturek, M	1
Lee, RJ; Li, C; Lu, JH; Meng, QF; Song, J; Teng, LS; Wang, D; Xie, J; Yang, Z	1
Katara, R; Majumdar, DK; Meena, J; Panda, A	1
Choi, S; Garner, J; Park, H; Park, K; Skidmore, S; Wang, Y	2
Burgess, DJ; Choi, S; Qu, W; Shen, J; Wang, Y	1
He, HB; Lin, X; Tang, X; Xu, YH; Zhang, Y	1
Park, K	1
Chen, J; Lin, X; Tang, X; Wang, J; Xu, Y; Yang, Z; Zhang, Y	1
Averianov, I; Korzhikov, V; Litvinchuk, E; Tennikova, TB	1
An, T; Choi, J; Hwang, SJ; Kim, A; Kim, CJ; Lee, JH; Nam, Y; Park, J; Suh, H; Sun, Bk	1
Gao, Y; Guo, J; Hu, X; Li, M; Li, Z; Liu, C; Liu, Y; Ma, S; Mei, X; Tang, X; Yang, Y; Yu, F; Zhang, J; Zhang, Y	1
Chen, X; Fu, H; Huang, Y; Huang, Z; Ma, C; Pan, X; Wen, X; Wu, C; Zhang, J	1
Bao, Q; Burgess, DJ; Qin, B; Wan, B; Wang, R; Wang, X; Wang, Y	1

Other Studies

29 other study(ies) available for risperidone and lactic acid

Article	Year
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Microdialysis in the management of hepatic encephalopathy. Neurocritical care, 2006, Volume: 5, Issue:3 Topics: Acetaminophen; Analgesics, Non-Narcotic; Blood Glucose; Brain; Brain Edema; Critical Care; Dextropropoxyphene; Drug Combinations; Drug Interactions; Extracellular Fluid; Female; Frontal Lobe; Glucose; Hepatic Encephalopathy; Humans; Intracranial Pressure; Lactic Acid; Liver Failure, Acute; Microdialysis; Middle Aged; Pyruvic Acid; Risperidone	2006
[Rheological properties of sucrose acetate isobutyrate in situ gel]. Yao xue xue bao = Acta pharmaceutica Sinica, 2007, Volume: 42, Issue:4 Topics: Antipsychotic Agents; Delayed-Action Preparations; Drug Carriers; Ethanol; Lactates; Lactic Acid; Polyesters; Polymers; Pyrrolidinones; Rheology; Risperidone; Solvents; Sucrose; Temperature; Viscosity	2007
Sucrose acetate isobutyrate as an in situ forming system for sustained risperidone release. Journal of pharmaceutical sciences, 2007, Volume: 96, Issue:12 Topics: Animals; Antipsychotic Agents; Chemistry, Pharmaceutical; Delayed-Action Preparations; Drug Carriers; Drug Compounding; Excipients; Hydrogen-Ion Concentration; Injections, Intramuscular; Kinetics; Lactic Acid; Male; Materials Testing; Models, Chemical; Muscle, Skeletal; Particle Size; Polyesters; Polymers; Rats; Rats, Wistar; Rheology; Risperidone; Solubility; Solvents; Sucrose; Technology, Pharmaceutical; Viscosity	2007
In vitro and in vivo demonstration of risperidone implants in mice. Schizophrenia research, 2008, Volume: 98, Issue:1-3 Topics: Animals; Behavior, Animal; Biocompatible Materials; Disease Models, Animal; Drug Delivery Systems; Drug Design; Drug Implants; Evoked Potentials, Auditory; Humans; In Vitro Techniques; Lactic Acid; Mice; Mice, Inbred C57BL; Models, Animal; Patient Compliance; Polyesters; Polyglycolic Acid; Polymers; Reflex, Startle; Risperidone; Schizophrenia	2008
PLGA nanoparticle formulations of risperidone: preparation and neuropharmacological evaluation. Nanomedicine : nanotechnology, biology, and medicine, 2009, Volume: 5, Issue:3 Topics: Animals; Apomorphine; Behavior, Animal; Catalepsy; Drug Compounding; Lactic Acid; Mice; Microscopy, Atomic Force; Movement; Nanoparticles; Nervous System; Particle Size; Poloxamer; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Risperidone; Solutions; Treatment Outcome	2009
Effects of formulation parameters on encapsulation efficiency and release behavior of risperidone poly(D,L-lactide-co-glycolide) microsphere. Chemical & pharmaceutical bulletin, 2009, Volume: 57, Issue:11 Topics: Animals; Dogs; Drug Compounding; Drug Evaluation, Preclinical; Lactic Acid; Microspheres; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Risperidone; Surface Properties; Viscosity	2009
Biodegradable poly(D, L-lactide-co-glycolide) (PLGA) microspheres for sustained release of risperidone: Zero-order release formulation. Pharmaceutical development and technology, 2011, Volume: 16, Issue:4 Topics: Antipsychotic Agents; Chemistry, Pharmaceutical; Delayed-Action Preparations; Lactic Acid; Microspheres; Molecular Weight; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Risperidone; Schizophrenia; Solubility	2011
In vitro-in vivo correlations of scalable PLGA-risperidone implants for the treatment of schizophrenia. Pharmaceutical research, 2010, Volume: 27, Issue:8 Topics: Absorbable Implants; Animals; Antipsychotic Agents; Drug Delivery Systems; Humans; Lactic Acid; Male; Models, Animal; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Sprague-Dawley; Risperidone; Schizophrenia	2010
Effect of bases with different solubility on the release behavior of risperidone loaded PLGA microspheres. Colloids and surfaces. B, Biointerfaces, 2011, Aug-01, Volume: 86, Issue:1 Topics: Lactic Acid; Microscopy, Electron, Scanning; Microspheres; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Risperidone; Solubility; X-Ray Diffraction	2011
Validation of USP apparatus 4 method for microsphere in vitro release testing using Risperdal Consta. International journal of pharmaceutics, 2011, Nov-28, Volume: 420, Issue:2 Topics: Antipsychotic Agents; Chemistry, Pharmaceutical; Delayed-Action Preparations; Drug Carriers; Hydrogen-Ion Concentration; Lactic Acid; Microspheres; Molecular Weight; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Reproducibility of Results; Risperidone; Temperature	2011
A novel risperidone-loaded SAIB-PLGA mixture matrix depot with a reduced burst release: effects of solvents and PLGA on drug release behaviors in vitro/in vivo. Journal of materials science. Materials in medicine, 2012, Volume: 23, Issue:2 Topics: Animals; Area Under Curve; Chromatography; Diffusion; Dopamine Antagonists; Drug Delivery Systems; Female; Hydrogen-Ion Concentration; Kinetics; Lactic Acid; Male; Microscopy; Optics and Photonics; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Porosity; Rats; Rheology; Risperidone; Solubility; Solvents; Time Factors	2012
Comparison of in vitro-in vivo release of Risperdal(®) Consta(®) microspheres. International journal of pharmaceutics, 2012, Sep-15, Volume: 434, Issue:1-2 Topics: Delayed-Action Preparations; Drug Carriers; Humans; Hydrogen-Ion Concentration; Lactic Acid; Microspheres; Phase Transition; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Quality Control; Risperidone; Temperature; Time Factors	2012
Accelerated polymer biodegradation of risperidone poly(D, L-lactide-co-glycolide) microspheres. AAPS PharmSciTech, 2012, Volume: 13, Issue:4 Topics: Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Hydrolysis; Kinetics; Lactic Acid; Microscopy, Electron, Scanning; Microspheres; Molecular Weight; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Polysorbates; Risperidone	2012
Microsphere delivery of Risperidone as an alternative to combination therapy. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 2013, Volume: 85, Issue:3 Pt A Topics: Animals; Antipsychotic Agents; Area Under Curve; Chemistry, Pharmaceutical; Delayed-Action Preparations; Drug Carriers; Drug Compounding; Drug Delivery Systems; Isoxazoles; Lactic Acid; Male; Microspheres; Paliperidone Palmitate; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Porosity; Pyrimidines; Rats; Rats, Sprague-Dawley; Risperidone; Time Factors	2013
Microparticles produced by the hydrogel template method for sustained drug delivery. International journal of pharmaceutics, 2014, Jan-30, Volume: 461, Issue:1-2 Topics: Delayed-Action Preparations; Drug Carriers; Drug Compounding; Drug Delivery Systems; Hydrogels; Lactic Acid; Methylprednisolone; Methylprednisolone Acetate; Molecular Weight; Paclitaxel; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Polyvinyl Alcohol; Risperidone; Solvents; Viscosity	2014
Near infrared spectroscopic (NIRS) analysis of drug-loading rate and particle size of risperidone microspheres by improved chemometric model. International journal of pharmaceutics, 2014, Sep-10, Volume: 472, Issue:1-2 Topics: Drug Carriers; Drug Compounding; Lactic Acid; Least-Squares Analysis; Microspheres; Models, Theoretical; Neural Networks, Computer; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Risperidone; Spectroscopy, Near-Infrared	2014
Formulation and characterization of clozapine and risperidone co-entrapped spray-dried PLGA nanoparticles. Pharmaceutical development and technology, 2016, Volume: 21, Issue:1 Topics: Chemistry, Pharmaceutical; Clozapine; Drug Carriers; Drug Combinations; Lactic Acid; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Risperidone; X-Ray Diffraction	2016
A protocol for assay of poly(lactide-co-glycolide) in clinical products. International journal of pharmaceutics, 2015, Nov-10, Volume: 495, Issue:1 Topics: Delayed-Action Preparations; Esters; Lactic Acid; Microspheres; Molecular Weight; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Risperidone; Triptorelin Pamoate	2015
In vitro-in vivo correlation of parenteral risperidone polymeric microspheres. Journal of controlled release : official journal of the Controlled Release Society, 2015, Nov-28, Volume: 218 Topics: Animals; Drug Carriers; Drug Liberation; Lactic Acid; Microspheres; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Porosity; Rabbits; Risperidone	2015
[Preparation and evaluation of risperidone-loaded microsphere/sucrose acetate isobutyrate in situ forming complex depot with double diffusion barriers]. Yao xue xue bao = Acta pharmaceutica Sinica, 2015, Volume: 50, Issue:6 Topics: Chitosan; Drug Carriers; Lactic Acid; Microspheres; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Risperidone; Sucrose; Technology, Pharmaceutical	2015
IVIVC of parenteral PLGA microspheres. Journal of controlled release : official journal of the Controlled Release Society, 2015, Nov-28, Volume: 218 Topics: Animals; Delayed-Action Preparations; Drug Delivery Systems; Drug Liberation; Lactic Acid; Microspheres; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rabbits; Risperidone	2015
Tracking the effect of microspheres size on the drug release from a microsphere/sucrose acetate isobutyrate (SAIB) hybrid depot in vitro and in vivo. Drug development and industrial pharmacy, 2016, Volume: 42, Issue:9 Topics: Animals; Delayed-Action Preparations; Diffusion; Drug Carriers; Drug Compounding; Drug Delivery Systems; Drug Liberation; Excipients; Lactic Acid; Male; Microspheres; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Wistar; Risperidone; Sucrose	2016
Polyester-based microparticles of different hydrophobicity: the patterns of lipophilic drug entrapment and release. Journal of microencapsulation, 2016, Volume: 33, Issue:3 Topics: Antipsychotic Agents; Crystallization; Delayed-Action Preparations; Dopamine Antagonists; Drug Liberation; Humans; Hydrophobic and Hydrophilic Interactions; Lactic Acid; Macrolides; Polyesters; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Risperidone; U937 Cells	2016
Sustained release of risperidone from biodegradable microspheres prepared by in-situ suspension-evaporation process. International journal of pharmaceutics, 2016, Apr-30, Volume: 503, Issue:1-2 Topics: Animals; Antipsychotic Agents; Delayed-Action Preparations; Dopamine Antagonists; Drug Compounding; Drug Liberation; Lactic Acid; Male; Microspheres; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats, Sprague-Dawley; Risperidone; Serotonin Antagonists	2016
An Accelerated Release Method of Risperidone Loaded PLGA Microspheres with Good IVIVC. Current drug delivery, 2018, Volume: 15, Issue:1 Topics: Animals; Drug Liberation; Ethanol; Hydrogen-Ion Concentration; Lactic Acid; Least-Squares Analysis; Microspheres; Osmotic Pressure; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Sprague-Dawley; Risperidone; Temperature	2018
Formation Mechanism and In Vitro Evaluation of Risperidone-Containing PLGA Microspheres Fabricated by Ultrafine Particle Processing System. Journal of pharmaceutical sciences, 2017, Volume: 106, Issue:11 Topics: Antipsychotic Agents; Delayed-Action Preparations; Diffusion; Drug Compounding; Drug Liberation; Lactic Acid; Microspheres; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Risperidone; Surface Properties; Viscosity	2017
Beyond Q1/Q2: The Impact of Manufacturing Conditions and Test Methods on Drug Release From PLGA-Based Microparticle Depot Formulations. Journal of pharmaceutical sciences, 2018, Volume: 107, Issue:1 Topics: Chemistry, Pharmaceutical; Drug Carriers; Drug Compounding; Drug Liberation; Kinetics; Lactic Acid; Microspheres; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Risperidone	2018
Reverse engineering of Perseris and development of compositionally equivalent formulations. International journal of pharmaceutics, 2023, May-25, Volume: 639 Topics: Humans; Lactic Acid; Microspheres; Pharmaceutical Preparations; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Risperidone	2023